328
Participants
Start Date
October 6, 2021
Primary Completion Date
December 2, 2022
Study Completion Date
December 2, 2022
OnabotulinumtoxinA X
Injection
Placebo
Injection
Skin Search of Rochester Inc. /ID# 242540, Rochester
Wilmington Dermatology Center /ID# 242544, Wilmington
Aventiv Research Dublin /ID# 232546, Dublin
Coleman Center For Cosmetic Dermatologic Surgery /ID# 230693, Metairie
Advanced Research Associates - Glendale /ID# 230418, Glendale
Premier Clinical Research /ID# 230682, Spokane
Westside Aesthetics /ID# 230305, Los Angeles
The Eye Research Foundation /ID# 232544, Newport Beach
The Research Center at The Maas Clinic /ID# 230685, San Francisco
Center for Dermatology and Dermatologic Surgery /ID# 230684, Washington D.C.
Steven Fagien MD Aesthetic Eyelid Plastic Surgery /ID# 232542, Boca Raton
Baumann Cosmetic and Research Institute /ID# 232545, Miami
Research Institute of the Southeast, LLC /ID# 230436, West Palm Beach
Etre Cosmetic Dermatology and Laser Center /ID# 230437, New Orleans
SLUCare Cosmetic Dermatology /ID# 230333, St Louis
Laser & Skin Surgery Center of New York /ID# 230683, New York
Aesthetic Solutions /ID# 230716, Chapel Hill
Westlake Dermatology & Cosmetic Surgery - Westlake /ID# 232543, Austin
Lead Sponsor
Allergan
INDUSTRY